About 1,938 results

ALLMedicine™ Folliculitis Center

Research & Reviews  544 results

Position statement: Recommendations on the diagnosis and treatment of Malassezia follic...
Journal of the European Academy of Dermatology and Venere... Henning MAS, Hay R et. al.

Mar 14th, 2023 - Malassezia is a lipophilic yeast that is a part of the human mycobiome. Malassezia folliculitis appears when the benign colonization of the hair follicles, by the Malassezia yeasts, becomes symptomatic with pruritic papules and pustules. Although ...

Risk factors for skin injuries in cancer patients with peripherally inserted central ca...
The Journal of Vascular Access; Wang R, Li Y et. al.

Mar 11th, 2023 - The risk factors for skin injuries remain poorly understood in cancer patients with peripherally inserted central catheters (PICC). We herein aimed at exploring the effect of clinical factors on the risk of PICC-related skin injuries. We included ...

Eosinophilic pustular folliculitis in infancy: a rare disease
European Journal of Dermatology : EJD; Ashworth J, Nogueira M et. al.

Mar 2nd, 2023 - Eosinophilic pustular folliculitis in infancy: a rare disease|2023|Ashworth J,Nogueira M,Freitas E,Ferreira L,Tente D,|

Tufted Hair Folliculitis: Doll's Hair.
Journal of Cutaneous Medicine and Surgery; Zhang LW, Chen T

Feb 24th, 2023 - Tufted Hair Folliculitis: Doll's Hair.|2023|Zhang LW,Chen T,|

Development of a new classification and scoring system for scalp conditions: Scalp Phot...
The Journal of Dermatological Treatment; Kim BR, Won SH et. al.

Feb 23rd, 2023 - There has been no validated tool for objectively quantifying the overall condition and characteristics of the scalp. This study aimed to establish and validate a new classification and scoring system for evaluating scalp conditions. The Scalp Phot...

see more →

Drugs  51 results see all →

Clinicaltrials.gov  17 results

Duobrii Treatment of Acne Keloidalis Nuchae (AKN)

Nov 8th, 2022 - Acne keloidalis nuchae (AKN) is one of the chronic forms of scarring folliculitis, affecting predominantly the occipital scalp, seen mostly in men of African descent. Duobrii has the advantage of being the only high potency topical steroid-retinoi...

Effect of Cold Atmospheric Plasma on Malassezia Folliculitis

Sep 22nd, 2022 - Malassezia folliculitis is a common disease of young and middle-aged people. It is an inflammatory disease caused by Malassezia infection. Generally, Topical or systemic use of antifungal drugs are the first choice for treatment but sometimes are ...

Evaluation of Safety and Performance of Ialuxid Gel in Treatment of Acne Vulgaris, Impetigo and Folliculitis

May 2nd, 2022 - Ialuxid® Gel is a non-antibiotic treatment in gel indicated for use in a variety of skin conditions, and also in case of infection. Its principal ingredient is Ialuvance™ Complex, a proprietary association of hydrogen peroxide, hyaluronic acid, an...

Effect of Various Treatment Modalities on Dendritic Vial Ulcer

Apr 6th, 2022 - Eye infection is a prevalent problem in primary care and remains a crucial healthcare concern. According to the American Academy of Ophthalmology (AAO), herpes simplex virus (HSV) keratitis (HSK) is the leading cause of infectious blindness worldw...

Skin bioMARkers for Atopic Eczema Therapy Evaluation

Dec 14th, 2021 - The first-line drug treatment for mild-moderate AD are currently topical corticosteroids (TCS) with recognized efficacy. However, their prolonged or inappropriate use, can lead to local adverse effects. Side-effects of topical corticosteroids comp...

see more →

News  146 results

More New Therapeutics for Psoriasis
Christina Kontzias, BA, Steven R. Feldman, MD, PhD

Jan 31st, 2023 - New treatments for psoriasis constitute an embarrassment of riches compared to any other area of dermatology. Despite the many advances over the last 25 years, additional topical and systemic treatments have recently become available.

HS treated in EDs not followed up in derm clinics, study finds
Lorraine L. Janeczko, MPH

Dec 1st, 2022 - Many patients with hidradenitis suppurativa (HS) return to emergency departments – not to dermatology clinics – for their ongoing care, according to a study of a large national administrative data set. “Patients with HS presenting to the ED for th.

HS Treated in EDs Not Followed Up in Derm Clinics, Study Finds

Dec 1st, 2022 - Many patients with hidradenitis suppurativa (HS) return to emergency departments – not to dermatology clinics – for their ongoing care, according to a study of a large national administrative data set. “Patients with HS presenting to the ED for th...

First TYK2 Inhibitor for Psoriasis Wins FDA Approval

Sep 11th, 2022 - The FDA approved the first-in-class oral tyrosine kinase 2 (TYK2) inhibitor deucravacitinib (Sotyktu) for moderate-to-severe plaque psoriasis, Bristol Myers Squibb announced. The indication limits use to adults who are candidates for systemic ther...

FDA Approves First Systemic Treatment for Alopecia Areata

Jun 13th, 2022 - The FDA approved the Janus kinase (JAK) inhibitor baricitinib (Olumiant) as the first systemic treatment for alopecia areata. The approval pertains to adults with severe alopecia areata, which affects more than 300,000 people in the U.S. each year...

see more →

Patient Education  17 results see all →